The 2023-2028 World Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests

The 2023-2028 World Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests

This study covers the world outlook for viral hepatitis and retrovirus diagnostic tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

This study covers viral hepatitis and retrovirus diagnostic tests as defined by the North American Industrial Classification system or NAICS (pronounced nakes).

The NAICS code for viral hepatitis and retrovirus diagnostic tests is 3391151. It is for this definition that aggregate latent demand estimates are derived. Viral hepatitis and retrovirus diagnostic tests is specifically defined as follows:

3391151 Eyeglass frames (without lenses inserted) and frame parts

33911511 Ophthalmic fronts and temples

3391151101 Ophthalmic plastics finished fronts

3391151106 Other ophthalmic finished fronts

3391151111 Plastic ophthalmic temples

3391151116 Other ophthalmic temples

3391151121 Ophthalmic temples